1. Home
  2. NERV vs LARK Comparison

NERV vs LARK Comparison

Compare NERV & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.11

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

HOLD

Current Price

$30.37

Market Cap

185.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NERV
LARK
Founded
2007
1885
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
210.1M
185.5M
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
NERV
LARK
Price
$4.11
$30.37
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.50
N/A
AVG Volume (30 Days)
358.2K
13.7K
Earning Date
05-01-2026
04-29-2026
Dividend Yield
N/A
3.07%
EPS Growth
N/A
35.84
EPS
N/A
0.83
Revenue
$41,175,600.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$37.23
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$23.57
52 Week High
$12.46
$32.39

Technical Indicators

Market Signals
Indicator
NERV
LARK
Relative Strength Index (RSI) 40.62 60.04
Support Level $3.80 $25.29
Resistance Level $4.59 $32.39
Average True Range (ATR) 0.38 0.53
MACD -0.01 -0.04
Stochastic Oscillator 18.81 79.81

Price Performance

Historical Comparison
NERV
LARK

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

Share on Social Networks: